WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.


CLSI H02

Procedures for the Erythrocyte Sedimentation Rate Test, 5th Edition

This document provides a description of the principle, materials, and procedure for a standardized erythrocyte sedimentation rate (ESR) method; a selected routine method, as well as a procedure to evaluate routine methods; and an outline of quality control programs for the ESR test.

This document is available in electronic format only.

Member price:

List Price:
  PDF  Add to Cart
Log in/sign up to see your price

Details

Chairholder: Dorothy M. Adcock, MD

Date of Publication: May 31, 2011

Order Code PDF: CLSI H02A5E
ISBN Number: 1-56238-753-7

Order Code Print: print not available

Edition: Fifth

Pages: 36

CLSI H02 Additional Details

If interested in ordering larger quantities of this document in print, please contact us here.

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.

CLSI H02 Abstract

Clinical and Laboratory Standards Institute document H02-A5—Procedures for the Erythrocyte Sedimentation Rate Test; Approved Standard—Fifth Edition is a revision of the fourth edition approved standard (H02-A4) published in December 2000. The document outlines the necessary details for the performance of a standardized (Westergren) method on diluted (1:4) blood specimens for the determination of the erythrocyte sedimentation rate (ESR). Quality assurance and evaluation of other methods to measure the ESR are also described, including procedures for the preparation of a fresh blood reference material for use in the laboratory or manufacturing of ESR devices. This standard provides guidance for the validation, verification, quality assurance, and quality control of ESR measurement devices or related controls. The intended audience includes manufacturers of such devices, end-user clinical laboratories, accrediting organizations, and regulatory bodies.